{"id":"W4226052234","doi":"10.1136/gutjnl-2021-326259","title":"CXCR2 inhibition enables NASH-HCC immunotherapy","year":2022,"lang":"en","type":"article","venue":"Gut","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":228,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Infection and Immunity; Institute of Cancer Research","funders":"European Social Fund; National Institute of Diabetes and Digestive and Kidney Diseases; Instituto de Salud Carlos III; Medical Research Council; Genentech; National Institutes of Health; Fakultet Medicinskih Nauka, Univerziteta U Kragujevcu; Agència de Gestió d'Ajuts Universitaris i de Recerca; Associazione Italiana per la Ricerca sul Cancro; Eisai; Ministerio de Ciencia e Innovación; Fundación Científica Asociación Española Contra el Cáncer; Generalitat de Catalunya; Exelixis; Bayer HealthCare; Cancer Research UK; Wellcome Trust; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Deutsche Forschungsgemeinschaft; Ipsen; Samuel Waxman Cancer Research Foundation","keywords":"Cancer research; Immunotherapy; CXC chemokine receptors; CD8; Immunology; Granzyme B; Cytotoxic T cell; Biology; Tumor microenvironment; Immune system; Medicine; Chemokine; Chemokine receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001429559,0.00006552653,0.0001311643,0.00005387519,0.0001389911,0.000009096903,0.00003088776,0.00002224844,0.004522307],"category_scores_gemma":[0.00001027451,0.00006039273,0.00007015559,0.000129588,0.00001433983,0.00002608316,0.00003424585,0.0001461916,0.00003719464],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008548253,"about_ca_system_score_gemma":0.00004306253,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005438978,"about_ca_topic_score_gemma":0.000001347725,"domain_scores_codex":[0.9994119,0.00002125405,0.0001212579,0.0001204632,0.0001944396,0.0001306327],"domain_scores_gemma":[0.9997623,0.0000173402,0.00003359053,0.0001286638,0.00002245265,0.0000356635],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001300696,0.0001692552,0.003205814,0.00003661422,0.00004687704,0.00004447825,0.0008148456,0.00004279857,0.9542831,0.0004378743,0.0217789,0.0190094],"study_design_scores_gemma":[0.002824392,0.0003778489,0.001444595,0.00005281124,0.00002904212,0.0001866094,0.001114441,0.0002425964,0.1653327,0.0006016169,0.8275919,0.0002013905],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914308,0.001088018,0.000123763,0.001158517,0.0001922561,0.0001353733,0.000006761892,0.00006678973,0.005797723],"genre_scores_gemma":[0.9943933,0.00007056857,0.0002284584,0.001011294,0.0002529426,0.00003031355,0.00006695503,0.00001815847,0.003928041],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.805813,"threshold_uncertainty_score":0.9963877,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01192174564657224,"score_gpt":0.2461518140211763,"score_spread":0.234230068374604,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}